Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG - World Stem Cell Summit

Probing the Mysteries of the Aging Brain

by admin | Mar 28, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Dennis Nealon – Harvard Research – Research led by new faculty member Michael Segel focuses on mammalian lifespans Sixteen years ago, Michael Segel was a rising senior at Brookline High School in Massachusetts when, acting on a friend’s suggestion, he...

Cells That Build Themselves Into an Embryo? Scientists Just Made It Happen

by admin | Mar 27, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By University of California – Santa Cruz – SciTechDaily – Scientists have found a way to study early embryonic development without real embryos. Using CRISPR, they programmed stem cells to self-organize into structures mimicking early embryos. The...

Will Stem Cell Clinics Flourish Under RFK Jr.?

by admin | Mar 26, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By by Rachael Robertson MedPageToday – After HHS Secretary Robert F. Kennedy Jr. hosted a roundtableopens in a new tab or window on reducing regulations on stem cells earlier this month, experts have raised concerns about a potential flourishing of questionable...

Clinical Trial Tests Novel Stem Cell Treatment for Parkinson’s Disease

by admin | Mar 25, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Technology Networks – Reprogrammed stem cells to replace dopamine cells in the brain may offer hope for Parkinson’s treatment. A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking...

Clinical Trial Tests Novel Stem-Cell Treatment for Parkinson’s Disease

by admin | Mar 24, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Mass General Brigham – A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem cells are reprogrammed to replace...

Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder

by admin | Mar 21, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Frank Vinluan – MedCity News – Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder....